Shell Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153K | Sell |
5,158
-1,244
| -19% | -$36.9K | 0.01% | 855 |
|
|
2025
Q1 | $191K | Sell |
6,402
-159
| -2% | -$4.74K | 0.01% | 812 |
|
|
2024
Q4 | $188K | Hold |
6,561
| – | – | 0.01% | 859 |
|
|
2024
Q3 | $254K | Buy |
+6,561
| New | +$254K | 0.01% | 742 |
|
|
2024
Q1 | $223K | Sell |
6,930
-722
| -9% | -$23.2K | 0.01% | 777 |
|
|
2023
Q4 | $236K | Sell |
7,652
-2,327
| -23% | -$71.8K | 0.01% | 793 |
|
|
2023
Q3 | $223K | Sell |
9,979
-156
| -2% | -$3.49K | 0.01% | 867 |
|
|
2023
Q2 | $218K | Sell |
10,135
-56
| -0.5% | -$1.21K | 0.01% | 888 |
|
|
2023
Q1 | $244K | Sell |
10,191
-36
| -0.4% | -$862 | 0.01% | 862 |
|
|
2022
Q4 | $237K | Sell |
10,227
-2,086
| -17% | -$48.3K | 0.01% | 879 |
|
|
2022
Q3 | $197K | Sell |
12,313
-3,241
| -21% | -$51.9K | 0.01% | 1017 |
|
|
2022
Q2 | $276K | Buy |
15,554
+6,121
| +65% | +$109K | 0.01% | 1015 |
|
|
2022
Q1 | $192K | Sell |
9,433
-1,395
| -13% | -$28.4K | ﹤0.01% | 1168 |
|
|
2021
Q4 | $202K | Buy |
10,828
+51
| +0.5% | +$951 | ﹤0.01% | 1206 |
|
|
2021
Q3 | $213K | Sell |
10,777
-460
| -4% | -$9.09K | ﹤0.01% | 1185 |
|
|
2021
Q2 | $266K | Buy |
11,237
+7,040
| +168% | +$167K | 0.01% | 1157 |
|
|
2021
Q1 | $99K | Buy |
+4,197
| New | +$99K | ﹤0.01% | 1289 |
|